Back to Trials
NCT07002034PHASE2Recruiting

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Reunion Neuroscience Inc

Start Date

7/30/2025

Completion Date

12/1/2026

Summary

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to active-placebo.

Eligibility Criteria

Age Range: 18 years to 80 years

Inclusion Criteria: * Has a ≥4 week history of AjD as defined by DSM-5-TR with either depressed mood, or mixed anxiety and depressed mood confirmed by clinical interview with evidence that the AjD was instigated by one of the following medical illnesses (e.g., diagnosis, impact, management, recurrence, prognosis): Cancer, ALS, MS, PD or IPF * Is sufficiently ambulatory and capable of self care as necessary to complete study procedures * Has normal cognitive function * Is on stable use of antidepressants or psychotherapy, or is willing to delay use until the end of study * If female is not pregnant or planning to become pregnant. If male is not planning to make a partner pregnant * Is willing and able to comply with the conditions and requirements of the study Exclusion Criteria: * Has a significant risk of suicide * Has active or medical history of bipolar disorder, schizophrenia, schizoaffective disorder, psychotic disorder and/or borderline personality disorder, or first-degree family history of psychosis or bipolar disorder * Has active or a history of central nervous system malignancy * Has other medically significant conditions rendering unsuitability for the study * Has used or will need to use prohibited medications or therapies * Has a known sensitivity or intolerance to study intervention or potential rescue medications

Interventions

DRUG

RE104 for Injection

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Adjustment Disorder

Locations

UAB, Psychiatry and Behavioral Neurology

Birmingham, Alabama 35209

United States

University of Arizona

Tucson, Arizona 85724

United States

Kadima Neuropsychiatry Institute

San Diego, California 92037

United States

Providence Medical Foundation

Santa Rosa, California 95403

United States

University of Colorado

Aurora, Colorado 80045

United States

University of South Florida, Department of Psychiatry and Behavioral Neuroscience

Tampa, Florida 33613

United States

Emory University

Atlanta, Georgia 30329

United States

Hawaii Pacific Neuroscience

Honolulu, Hawaii 96817

United States

Rush University Medical Center

Chicago, Illinois 60612

United States

The University of Kansas Medical Center

Kansas City, Kansas 66160

United States

LSU Health Shreveport

Shreveport, Louisiana 71103

United States

Sunstone Therapies, PC

Rockville, Maryland 20850

United States

Sheppard Pratt

Towson, Maryland 21204

United States

Dana Farber Cancer Institute

Boston, Massachusetts 02215

United States

University of Michigan

Ann Arbor, Michigan 48109

United States

Henry Ford Health

Novi, Michigan 48377

United States

University of Nebraska Medical Center

Omaha, Nebraska 68198

United States

University of New Mexico, School of Medicine

Albuquerque, New Mexico 87131

United States

Roswell Park Center Institute

Buffalo, New York 14263

United States

NYU Langone Center for Psychedelic Medicine

New York, New York 10016

United States

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina 27514

United States

Cleveland Clinic

Cleveland, Ohio 44113

United States

The Ohio State University, Department of Psychiatry

Columbus, Ohio 43210

United States

University of Pennsylvania

Philadelphia, Pennsylvania 19104

United States

Alliance for Multispecialty Research Clinical

Knoxville, Tennessee 37920

United States

Dell Medical School, University of Texas at Austin

Austin, Texas 78712

United States

Cedar Clinical Research Inc.

Draper, Utah 84020

United States

UVA Center for Psychiatric Clinical Research

Charlottesville, Virginia 22903

United States

Seattle Neuropsychiatric Treatment Center

Seattle, Washington 98104

United States

University of Wisconsin at Madison

Madison, Wisconsin 53792

United States